September 4, 2018 / 9:50 AM / 3 months ago

BRIEF-Santhera Hopes for Good News to Lift Shares, Pave Way For Capital Hike

Sept 4 (Reuters) - Santhera Pharmaceuticals Holding AG :

* SAYS EXPECTS 50 MILLION SFR SALES OF RAXONE WITHIN 2-3 YEARS‍​

* SAYS 50 MILLION SFR RAXONE SALES FORECAST PERTAINS TO LHON INDICATION IN EUROPE

* SANTHERA CEO SAYSNEEDS SUPPORTING NEWS FLOW, IMPROVED SHARE PRICE BEFORE SEEKING TO RAISE CAPITAL

* SANTHERA CEO SAYS CLEAR THAT MORE RESOURCES NEEDED TO ACHIEVE AMBITIOUS GOALS

* SANTHERA CFO SAYS HAD TO POSTPONE CAPITAL INCREASE EARLIER THIS YEAR WHEN EUROPEAN REGULATORS DECLINED TO RECOMMEND MAIN MEDICINE FOR DMD

* SANTHERA CFO SAYS DOESN’T WANT TO INCREASE DEBT, NO PLANS FOR ADDITIONAL CONVERTIBLE BONDS Source text for Eikon: Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below